Description
Seeking men and women with a specific form of lung cancer to test if a combination of two specific drugs is beneficial.
Overview
We are studying the effects of a combination of two specific drugs (tepotinib and ramucirumab) to see if they are able to help participants who have a specific form of advanced non-small cell lung cancer.
What we're hoping for
To determine if this combination of drugs is able to lower the chance of cancer growing and spreading as well as whether they will lower the chance of developing side effects related to treatment.
Additional Information
ClinicalTrials.gov Identifier: NCT06031688